ES521371A0 - A PROCEDURE FOR THE PURIFICATION OF AN ANTIBODY. - Google Patents

A PROCEDURE FOR THE PURIFICATION OF AN ANTIBODY.

Info

Publication number
ES521371A0
ES521371A0 ES521371A ES521371A ES521371A0 ES 521371 A0 ES521371 A0 ES 521371A0 ES 521371 A ES521371 A ES 521371A ES 521371 A ES521371 A ES 521371A ES 521371 A0 ES521371 A0 ES 521371A0
Authority
ES
Spain
Prior art keywords
antibody
purification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521371A
Other languages
Spanish (es)
Other versions
ES8404858A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES521371A0 publication Critical patent/ES521371A0/en
Publication of ES8404858A1 publication Critical patent/ES8404858A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES521371A 1982-04-12 1983-04-11 Method of affinity purification employing monoclonal antibodies. Expired ES8404858A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES521371A0 true ES521371A0 (en) 1984-05-16
ES8404858A1 ES8404858A1 (en) 1984-05-16

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Expired ES8404858A1 (en) 1982-04-12 1983-04-11 Method of affinity purification employing monoclonal antibodies.
ES528000A Expired ES8506902A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.
ES528001A Expired ES8706964A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528000A Expired ES8506902A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.
ES528001A Expired ES8706964A1 (en) 1982-04-12 1983-12-13 Method of affinity purification employing monoclonal antibodies.

Country Status (11)

Country Link
EP (1) EP0105359A4 (en)
AT (1) AT393386B (en)
AU (1) AU622099B2 (en)
CA (1) CA1209907A (en)
CH (1) CH672028A5 (en)
DK (1) DK192191D0 (en)
ES (3) ES8404858A1 (en)
FI (1) FI88403C (en)
GB (1) GB2128630B (en)
IT (1) IT1219779B (en)
WO (1) WO1983003678A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (en) * 1987-03-06 1993-02-22 Perstorp Biolytica ADSORBENT FOR ISOCRATIC AFFINITY CHROMATOGRAPHY
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
DE3871799D1 (en) * 1987-07-14 1992-07-09 Univ Manchester METHOD FOR DIAGNOSIS OF INFECTIONS IN WHICH LIPOPOLYSCACCHARIDANTIGENS ARE DETERMINED.
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
CA2266341A1 (en) * 1996-09-20 1998-03-26 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
MY195714A (en) * 2008-04-11 2023-02-07 Chugai Pharmaceutical Co Ltd Antigen-Binding Molecule Capable of Binding to Two or More Antigen Molecules Repeatedly
KR102385507B1 (en) 2010-11-30 2022-04-12 추가이 세이야쿠 가부시키가이샤 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
CA2827923C (en) 2011-02-25 2021-11-23 Chugai Seiyaku Kabushiki Kaisha Fc.gamma.riib-specific fc antibody
WO2013047748A1 (en) 2011-09-30 2013-04-04 中外製薬株式会社 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
RU2739792C1 (en) 2011-11-30 2020-12-28 Чугаи Сейяку Кабусики Кайся Carrier containing a drug into a cell for forming an immune complex
HUE056489T2 (en) 2014-12-19 2022-02-28 Chugai Pharmaceutical Co Ltd Anti-c5 antibodies and methods of use
MA41294A (en) 2014-12-19 2017-11-08 Chugai Pharmaceutical Co Ltd ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING FC REGION VARIANTS, AND METHODS OF USE
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
AU2017305073B2 (en) 2016-08-05 2024-02-01 Chugai Seiyaku Kabushiki Kaisha Composition for prevention or treatment of IL-8 related diseases
US11608374B2 (en) 2017-01-30 2023-03-21 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (en) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Method for purifying Fc fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
AU558931B2 (en) * 1981-02-26 1987-02-12 Unilever Plc A process and apparatus for the recovery of immunoglobulins
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
EP0105359A4 (en) 1984-08-20
ES528000A0 (en) 1985-08-01
CH672028A5 (en) 1989-10-13
IT1219779B (en) 1990-05-24
GB2128630B (en) 1986-08-28
ES8706964A1 (en) 1987-07-01
ES528001A0 (en) 1987-07-01
ES8404858A1 (en) 1984-05-16
DK192191A (en) 1991-11-26
AU7256987A (en) 1987-09-03
AU622099B2 (en) 1992-04-02
EP0105359A1 (en) 1984-04-18
FI834530A (en) 1983-12-09
DK192191D0 (en) 1991-11-26
ATA901983A (en) 1991-03-15
IT8320550A0 (en) 1983-04-12
GB8332644D0 (en) 1984-01-11
CA1209907A (en) 1986-08-19
FI88403B (en) 1993-01-29
FI88403C (en) 1993-05-10
ES8506902A1 (en) 1985-08-01
AT393386B (en) 1991-10-10
GB2128630A (en) 1984-05-02
FI834530A0 (en) 1983-12-09
WO1983003678A1 (en) 1983-10-27

Similar Documents

Publication Publication Date Title
ES521371A0 (en) A PROCEDURE FOR THE PURIFICATION OF AN ANTIBODY.
ES528627A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLO-AND PIRIDAZO-PIRAZOLINAS, -PIRIDAZINAS Y-DIAZEPINAS.
ES523858A0 (en) A PROCEDURE FOR THE PREPARATION OF BENZOTIENIL BENZOFURANIL OR NAFTIL-DERIVATIVES.
ES525175A0 (en) PROCEDURE FOR THE FORMATION OF AN ELASTIC COMPOUND.
ES501645A0 (en) A PROCEDURE FOR THE PREPARATION OF 6-ALQUILIDEN-PENAMAS.
ES506969A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRIMIDINAS SUBSTITUTES-IDAS.
ES505464A0 (en) A PROCEDURE FOR THE PREPARATION OF N-HETEROCICLILAMINOCARBONIL ARILSULFONAMIDAS.
ES520730A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOLACTAMAS.
ES530418A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLOPIRIDINAS.
ES507508A0 (en) A PROCEDURE FOR THE PREPARATION OF IMIDAZOLYLPHENYLAMI-DINAS.
ES503307A0 (en) A PROCEDURE FOR THE PREPARATION OF QUINOXALINYLOXIETERS.
ES521318A0 (en) A PROCEDURE FOR THE PREPARATION OF BENZMIDAZOLE COMPOUNDS.
ES515158A0 (en) A PROCEDURE FOR THE PREPARATION OF 2-GUANIDINO-4-HETEROARILTIAZOLES.
ES524346A0 (en) PROCEDURE FOR OBTAINING PRIMARY POLYAMINS.
ES521984A0 (en) A PROCEDURE FOR THE PRODUCTION OF RIBAVIRIN.
ES522120A0 (en) A PROCEDURE FOR THE PREPARATION OF 4-ARYL-4-PIPERIDINCARBINOLS.
ES527780A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW SPIRO-3-AZOLINDIONAS.
ES507919A0 (en) A PROCEDURE FOR THE PREPARATION OF ANTIALERGIC BENZOPYRANOTRIAZOLES.
ES523136A0 (en) A PROCEDURE FOR THE PREPARATION OF A COMPOUND.
ES514335A0 (en) A PROCEDURE FOR THE PREPARATION OF GUANIDINAS.
ES499936A0 (en) A PROCEDURE FOR THE PURIFICATION OF GLUCOSAMINOGLUCANS
ES506034A0 (en) A PROCEDURE FOR THE PREPARATION OF N-CARBOXIALKYL-DIPEPTIDES.
ES532777A0 (en) A PROCEDURE FOR THE PREPARATION OF ARICOXICICLOALCANOLAMINOLAMINOALQUILEN-ARIL-KETONAS.
ES520076A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRROPIRROLES.
ES520140A0 (en) A PROCEDURE FOR THE PREPARATION OF ACICLOGUANOSIN.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401